Thursday, May 23, 2019
Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'
A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?
Related Posts:
Opportunities for growth: Transitions for youth with autism spectrum disorder- Low Dose Birth Control Might Be The Wonder Pill You've Been Searching For
- What to Do If Your Baby Gets Hiccups in the Womb (No Glass of Water Required)
- What to Do When Depression Arrives to Mess with Your Morning
- 7 Ways to Show Care From Afar
0 comments:
Post a Comment